Sutton Wealth Advisors’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-217
Closed -$6.46K 1075
2022
Q4
$6.46K Buy
217
+211
+3,517% +$7.55K ﹤0.01% 1060
2022
Q3
$229 Sell
6
-310
-98% -$15.5K ﹤0.01% 1550
2022
Q2
$17.2K Buy
316
+5
+2% +$275 0.01% 726
2022
Q1
$19.4K Buy
311
+31
+11% +$2.04K 0.01% 715
2021
Q4
$28.2K Buy
280
+18
+7% +$1.58K 0.01% 605
2021
Q3
$23.6K Buy
262
+35
+15% +$3.18K 0.01% 643
2021
Q2
$20.9K Buy
227
+78
+52% +$6.23K 0.01% 687
2021
Q1
$14.4K Buy
+149
New +$15.4K 0.01% 772

Other funds holding FLGT

Sutton Wealth Advisors's FLGT Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Fulgent Genetics (FLGT) in Q1 2023, closing a stake of 217 shares — an estimated $6.46K sold.

Sutton Wealth Advisors first reported a position in FLGT in Q1 2021 and held it in 8 quarters. The position peaked at $28.2K in Q4 2021. 215 funds tracked by Wall St. Rank hold FLGT as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Fulgent Genetics position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 217 Fulgent Genetics shares in Q1 2023, an estimated $6.46K.
  • Sutton Wealth Advisors first reported a position in Fulgent Genetics in Q1 2021 and held it in 8 quarters.
  • Sutton Wealth Advisors's Fulgent Genetics position peaked at $28.2K in Q4 2021.
  • 215 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.